Literature DB >> 12910405

Intradural spinal seeding of a clival chordoma.

S Asano1, N Kawahara, T Kirino.   

Abstract

BACKGROUND: Following recent progress in radiological and surgical techniques for treating skull base tumours, more attention should be paid to the relatively rare phenomenon of intradural spinal seeding in cases of clival chordoma. CASE
PRESENTATION: A 53-year-old man harboured intradural spinal seeding from a clival chordoma 11 years after his initial surgical treatment. He had undergone skull base surgery five times with extra- and intradural approaches, and adjuvant radiotherapy. His complaints of lumbago, paraparesis, and sensory disturbance of the lower left extremity prompted us to carry out imaging studies of the spinal cord, which revealed multiple intradural, extramedullary mass lesions at the thoracic and lumbosacral spinal level. The tumours were histopathologically diagnosed as spinal seeding of the clival chordoma with high proliferative potential (Ki-67 labelling index of 8.4%).
INTERPRETATION: As long-term local control of skull base chordoma appears to be improving by the introduction of skull base surgical techniques and adjuvant radiotherapy, spinal intradural seeding might emerge as a potential complication. Close observation and timely imaging studies for spinal seeding of skull base chordoma would be required in long-term postoperative follow-ups, particularly for those patients with highly proliferative tumours.

Entities:  

Mesh:

Year:  2003        PMID: 12910405     DOI: 10.1007/s00701-003-0057-7

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  10 in total

1.  Clival chordoma manifesting as nasal bleeding. A case report.

Authors:  Ryuhei Kitai; Kazuhiko Yoshida; Toshihiko Kubota; Kazufumi Sato; Yuji Handa; Kazuma Kasahara; Hirofumi Nakajima
Journal:  Neuroradiology       Date:  2005-05-03       Impact factor: 2.804

2.  Clivus chordoma: is it enough to image the primary site?

Authors:  Shahzada K Ahmed; Hideyuki Murata; Wolfgang Draf
Journal:  Skull Base       Date:  2010-03

3.  Management challenges associated with a pineal region chordoma: illustrative case.

Authors:  Ji-Eyon Kwon; So Young Ji; Kihwan Hwang; Kyu Sang Lee; Gheeyoung Choe; Chae-Yong Kim; Jung Ho Han
Journal:  J Neurosurg Case Lessons       Date:  2021-06-14

4.  Recurrent L3 Chordoma Presented as Intradural Extramedullary Mass With Distant Metastasis: A Case Report.

Authors:  Soo Jin Jang; Nayoung Han; Eun Kyeong Hong; Ho-Shin Gwak
Journal:  Brain Tumor Res Treat       Date:  2022-04

5.  Metastatic disease from chordoma.

Authors:  Gloria Vergara; Belén Belinchón; Francisco Valcárcel; María Veiras; Irma Zapata; Alejandro de la Torre
Journal:  Clin Transl Oncol       Date:  2008-08       Impact factor: 3.405

Review 6.  Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma.

Authors:  Brian J Jian; Orin G Bloch; Isaac Yang; Seunggu J Han; Derick Aranda; Tarik Tihan; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-12-02       Impact factor: 4.130

7.  Ectopic Recurrence of Skull Base Chordoma after Proton Therapy.

Authors:  René G C Santegoeds; Mohammed Alahmari; Alida A Postma; Norbert J Liebsch; Damien Charles Weber; Hamid Mammar; Daniëlle B P Eekers; Yasin Temel
Journal:  Curr Oncol       Date:  2022-03-28       Impact factor: 3.109

Review 8.  Metastatic skull base chordoma: A systematic review.

Authors:  Kurtis Young; Torbjoern Nielsen; Hannah Bulosan; Tyler J Thorne; Christian T Ogasawara; Andrew C Birkeland; Dennis M Tang; Arthur W Wu; Toby O Steele
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-09

9.  Clival chordoma with an atypical presentation: a case report.

Authors:  Jaber Alshammari; Philippe Monnier; Roy T Daniel; Kishore Sandu
Journal:  J Med Case Rep       Date:  2012-11-29

10.  Simultaneous discovery of cranial and spinal intradural chordomas: case report.

Authors:  Yoshifumi Kawanabe; Shigeo Ueda; Nobuhiro Sasaki; Minoru Hoshimaru
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-01-28       Impact factor: 1.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.